Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
In laboratory settings, BPC-157 is analyzed for its role in angiogenic signaling and the maintenance of epithelial barrier stability
Clinical trials have demonstrated substantial weight losswith mean reductions up to approximately 21% of body weight at 72 weeks in the SURMOUNT-1 trialalongside meaningful improvements in hemoglobin A1c levels in patients with diabetes
Symptoms and custom notes for cycle changes, hunger, fatigue, or digestion
Systemic side effects are rare but include transient nausea (510% of patients, typically within the first hour post-injection) and allergic reactions to methylcobalamin or preservatives in compounded formulations
US$ 22.95
US$ 27.36
US$ 27.92
